Clinical trial
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in…
NCT00002327 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00002327 |
|---|---|
| Title | The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients |
| Official title | A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Condyloma Acuminatum in Patients With HIV Infection |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Condyloma Acuminata |
| Intervention type | Drug |
| Interventions | Cidofovir |
| Enrollment | 40 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: